Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,558 | 1,273 | 97.3% |
| Education | $328.30 | 10 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $234.21 | 15 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $3,351 | 214 | $0 (2024) |
| UCB, Inc. | $1,068 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,015 | 80 | $0 (2024) |
| ABBVIE INC. | $995.18 | 57 | $0 (2024) |
| Genentech USA, Inc. | $981.33 | 63 | $0 (2024) |
| EMD Serono, Inc. | $963.79 | 98 | $0 (2024) |
| GENZYME CORPORATION | $871.76 | 48 | $0 (2022) |
| SK Life Science, Inc. | $858.14 | 57 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $744.75 | 49 | $0 (2024) |
| Biogen, Inc. | $641.63 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,953 | 155 | UCB, Inc. ($445.46) |
| 2023 | $3,239 | 172 | UCB, Inc. ($366.09) |
| 2022 | $3,368 | 189 | Abbott Laboratories ($269.53) |
| 2021 | $2,927 | 186 | Teva Pharmaceuticals USA, Inc. ($577.30) |
| 2020 | $1,997 | 124 | Teva Pharmaceuticals USA, Inc. ($308.93) |
| 2019 | $2,142 | 142 | Teva Pharmaceuticals USA, Inc. ($616.57) |
| 2018 | $2,705 | 196 | Teva Pharmaceuticals USA, Inc. ($1,043) |
| 2017 | $1,790 | 134 | Teva Pharmaceuticals USA, Inc. ($292.68) |
All Payment Transactions
1,298 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Neuromodulation | ||||||
| 12/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: Neurology | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: PAIN | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Immunology | ||||||
| 12/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: PAIN | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: Neurology | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PAIN | ||||||
| 11/13/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 616 | 805 | $214,384 | $76,846 |
| 2022 | 12 | 517 | 669 | $165,464 | $61,992 |
| 2021 | 13 | 593 | 776 | $198,208 | $80,639 |
| 2020 | 9 | 501 | 628 | $136,803 | $50,324 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 202 | 317 | $71,642 | $29,776 | 41.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 69 | $20,838 | $9,854 | 47.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 44 | 44 | $18,480 | $7,324 | 39.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 52 | 52 | $17,680 | $6,082 | 34.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 30 | 60 | $12,120 | $5,220 | 43.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 30 | 30 | $12,900 | $5,117 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 59 | $9,204 | $3,586 | 39.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 18 | 18 | $7,200 | $2,885 | 40.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 39 | $5,850 | $2,330 | 39.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 22 | $4,752 | $1,889 | 39.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $5,160 | $1,860 | 36.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $4,004 | $1,582 | 39.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $3,740 | $1,255 | 33.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,442 | $1,006 | 41.2% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 17 | 18 | $2,196 | $873.72 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 174 | 252 | $55,567 | $18,567 | 33.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 82 | 82 | $27,487 | $10,114 | 36.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 49 | 50 | $20,611 | $8,271 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 90 | $13,580 | $4,441 | 32.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 20 | 40 | $7,503 | $3,280 | 43.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 42 | $6,170 | $2,503 | 40.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 34 | 38 | $3,016 | $1,865 | 61.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 18 | 20 | $2,366 | $983.06 | 41.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 14 | 14 | $504.31 | $299.60 | 59.4% |
About Dr. Ankit Patel, M.D
Dr. Ankit Patel, M.D is a Neurology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083979322.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankit Patel, M.D has received a total of $21,121 in payments from pharmaceutical and medical device companies, with $2,953 received in 2024. These payments were reported across 1,298 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($20,558).
As a Medicare-enrolled provider, Patel has provided services to 2,227 Medicare beneficiaries, totaling 2,878 services with total Medicare billing of $269,801. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Katy, TX
- Active Since 07/12/2012
- Last Updated 09/19/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1083979322
Products in Payments
- AJOVY (Drug) $1,061
- AJOVY (Biological) $983.08
- NUPLAZID (Drug) $744.75
- COPAXONE (Drug) $729.13
- KESIMPTA (Drug) $727.97
- OCREVUS (Biological) $727.01
- AUBAGIO (Drug) $702.78
- INFINITY (Device) $579.32
- APTIOM (Drug) $554.12
- NURTEC ODT (Drug) $490.91
- UBRELVY (Drug) $430.67
- ACTHAR (Biological) $364.46
- Gamunex-C (Biological) $360.66
- QULIPTA (Drug) $352.11
- Rebif (Biological) $347.68
- TECFIDERA (Drug) $346.65
- VALTOCO (Drug) $323.63
- GAMMAGARD (Biological) $314.86
- EMGALITY (Drug) $307.91
- ULTOMIRIS (Biological) $302.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Katy
Dr. Jose Diaz, M.d, M.D
Neurology — Payments: $105,577
Sevak Ohanian, Md, MD
Neurology — Payments: $20,220
Dr. Sadia Yasser, M.d, M.D
Neurology — Payments: $5,365
Shima Bozorgui, Md, Mph, MD, MPH
Neurology — Payments: $155.34
Ibrahim Noorbhai
Neurology — Payments: $40.16
Hannah Sutherland, Pt, Dpt, PT, DPT
Neurology